EPIS® Právní systém | Plné znění

XXXXXXXX KOMISE (EU) 2019/831

xx dne 22. xxxxxx 2019,

xxxxxx xx xxxx xxxxxxx XX, XXX x X xxxxxxxx Evropského xxxxxxxxxx x Xxxx (ES) č. 1223/2009 x xxxxxxxxxxxx přípravcích

(Xxxx s xxxxxxxx xxx EHP)

EVROPSKÁ XXXXXX,

x xxxxxxx xx Smlouvu x xxxxxxxxx Xxxxxxxx xxxx,

x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x Xxxx (ES) x. 1223/2009 xx xxx 30. xxxxxxxxx 2009 o kosmetických xxxxxxxxxxx (1), x xxxxxxx xx xx. 15 xxxx. 1, xx. 15 odst. 2 xxxxxx xxxxxxxxxxx a čl. 31 xxxx. 1 xxxxxxxxx nařízení,

xxxxxxxx x xxxxx xxxxxxx:

(1)

Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1272/2008 (2) xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx látek xxxx xxxxx xxxxxxxxxxxxxx, xxxxxxxxxxx xxxx xxxxxxxxx pro xxxxxxxxxx (XXX) xx xxxxxxx vědeckého xxxxxxxxx Xxxxxx xxx xxxxxxxxxx xxxxx Evropské xxxxxxxx xxx chemické látky. Xxxxx xxxx klasifikovány xxxx xxxxx XXX xxxxxxxxx 1 A, xxxxx XXX xxxxxxxxx 1X xxxx xxxxx CMR xxxxxxxxx 2 v závislosti xx xxxxxx důkazů x xxxxxx xxxxxxxxxxxx XXX.

(2)

Článek 15 nařízení (ES) x. 1223/2009 xxxxxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx podle xxxxx 3 xxxxxxx XX xxxxxxxx (XX) x. 1272/2008 (xxxxx XXX) xxxx xxxxx XXX xxxxxxxxx 1 X, xxxxxxxxx 1X xxxx xxxxxxxxx 2. Xxxxx XXX xxxx xxxx být x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, pokud xxxx xxxxxxx podmínky xxxxxxxxx x xx. 15 xxxx. 1 xxxxx xxxx xxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (ES) x. 1223/2009. Xxxxx xxxxxxxxx xx xxxxxxx xxxxxxxx (XX) x. 1223/2009. Vykládat xxxxx Xxxx, xxxxxx xxxxxx 15 nařízení (XX) x. 1223/2009, xx xxxxxxxx xxxxx Xxxxxx dvůr Xxxxxxxx xxxx.

(3)

V zájmu xxxxxxxxxx xxxxxxxxx xxxxxx látek XXX x xxxxx xxxxxxxxx xxxx, xxxxxxxxx xxxxxx xxxxxxx xxxxxxx pro xxxxxxxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx, xxxxx x xxxxxxxxx xxxxxx xxxxxx xxxxxxx lidského xxxxxx xx xxxxxxx xxxxx XXX xxxx xxx xxxxxxxx na xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009 a případně xxxxxx xx seznamů xxxxx xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx xxxxx v přílohách XXX a V uvedeného nařízení. Xxxxx xxxx xxxxxxx xxxxxxxx xxxxxxxxx x xx. 15 xxxx. 1 druhé větě xxxx v čl. 15 xxxx. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009, xxxxxxx xxxxx podléhajících xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx xx xxxx xxx odpovídajícím xxxxxxxx xxxxxxx.

(4)	Xxxx nařízení xx xxxxxxxx xx xxxxx, xxxxx xxxx podle xxxxxxxx (XX) č. 1272/2008 xxxxxxxxxxxxx jako xxxxx XXX xx xxx 1. xxxxxxxx 2018, kdy xx xxxxx xxxxxxxxxxx xxxxxxxx Xxxxxx (EU) 2017/776 (3).

(5)

Xxxxx xxx x xxxxxx látky XXX, xxx xxx xxxx předložena žádost x xxxxxxxxx použití x xxxxxxxxxxxx xxxxxxxxxxx, xxxxxx xxxxxxxxx, xx xxxx splněny xxxxxxx xxxxxxxx požadované x xx. 15 odst. 1 druhé xxxx xxxx x xx. 15 xxxx. 2 druhém xxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009. Xx xx xxxx xxxxx Xxxxxxxxxx-15, Xxxxxxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxxxx.

(6)

Xxxxx xxxxxxxxxx-3-xxxxxxxxxxxxxxxxx, jejíž xxxxx xxxxx Xxxxxxxxxxx xxxxxxxxxxxx kosmetických xxxxxx (XXXX) xxx Xxxxxxxxxx-15, xx x xxxxxxxx xxxx xxxxxxx v položce 31 xxxxxxx V nařízení (XX) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx xx 0,2 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxx-15 xx xxxx xxx- x xxxxx-xxxxxxx, xxxxx xxx-xxxxxx xxx xxxxxxxxx Xxxxxx (XX) č. 790/2009 (4) xxxxxxxxxxxx xxxx látka XXX kategorie 2. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx dne 1. xxxxxxxx 2010. V souladu s čl. 15 xxxx. 1 xxxxxx větou xxxxxxxx (XX) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, byla-li xxxxxxxxxx Xxxxxxxx xxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxx (dále xxx „XXXX“) a shledána xxxx bezpečná pro xxxxxxx v kosmetických xxxxxxxxxxx. Xx xxxxx 13. x 14. xxxxxxxx 2011 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx Xxxxxxxxxx-15 (xxx-xxxxxx) (5), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxxxxxxx xxxxx xxxxx stanovit xxxxxxxxxx xxxxxxx látky Xxxxxxxxxx-15 v kosmetických xxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxx-xxxxxxx xxxxxxxxxx v látce Xxxxxxxxxx-15 xxxx látky XXX xxxxxxxxx 2 x xx xxxxxxxxxx XXXX xx měla xxx xxxxx Xxxxxxxxxx-15 xxxxxx xx seznamu xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX uvedeného xxxxxxxx.

(7)

Xxxxx 2-xxxxxxxxxxxxx, xxxxx xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx, xx x xxxxxxxx době uvedena x xxxxxxx 41 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx do 0,3 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxxxxxxx byla xxxxx nařízení (XX) x. 1272/2008 xxxxxxxxxxxxx xxxx xxxxx CMR xxxxxxxxx 2. Xxxx klasifikace xx xxxxx použitelnou xxxx 1. prosincem 2010, xxx je datum, xxx se xxx xxxxx xxxxx použitelná xxxxxxxxxx hlav II, XXX x XX nařízení (XX) x. 1272/2008. V souladu x xx. 15 odst. 1 xxxxxx xxxxx xxxxxxxx (ES) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 použita x xxxxxxxxxxxx xxxxxxxxxxx, byla-li xxxxxxxxxx VVBS x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx x xxxxxxxx xxxxxxxxxxx. Xxx 22. března 2011 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx látky Xxxxxxxxxxxxxxx (6), xx xxxxxx xxxxxx k závěru, xx xx xxxxxxx xxxxxxxxxx xxxxx xxxx tato xxxxx xxx xxxxxxx x xxxxxxxxxxx xx 0,3 % xxxxxxxxxxxx v kosmetických přípravcích xxx xxxxxxxxxxxx xxxxxxxx. X xxxxxxx xx klasifikaci xxxxx Xxxxxxxxxxxxxxx xxxx xxxxx CMR kategorie 2 a na xxxxxxxxxx XXXX xx xxxx xxx xxxx xxxxx xxxxxx ze xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) č. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx II xxxxxxxxx nařízení.

(8)

Xxxxx xxxxxxxxxxxxx xx x xxxxxxxx době xxxxxxx x xxxxxxx 7 xxxxxxx XXX nařízení (XX) x. 1223/2009 jako xxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 35 % x xxxxxxxxx připraveném x xxxxxxx. Xxxxxxxxxxxxx xxx xxxxx nařízení (XX) x. 1272/2008 klasifikován xxxx xxxxx XXX kategorie 2. Tato xxxxxxxxxxx xx stala xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 1 xxxxxx xxxxx xxxxxxxx (XX) x. 1223/2009 xxxx xxx xxxxx klasifikovaná xxxx kategorie 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx XXXX x xxxxxxxx xxxx xxxxxxxx xxx použití x xxxxxxxx xxxxxxxxxxx. Dne 11. xxxxxxxx 2012 xxxxx VVBS xxxxxxx xxxxxxxxxx xxxxxxxx se xxxxx xxxxxxxxxxxxx (7). Xxx 25. xxxxxx 2015 xxxxx XXXX xxxx xxxxxxxxxx (8), které xxxx xxxxxxxxxx xxx 28. xxxxx 2015. X xxxxx revidovaném xxxxxxxxxx dospěl XXXX x xxxxxx, že xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxx xx 35 % x xxxxxx xx xxxxx x xxxx použití xx sprejích obecně xxxx xxxxxxxxxx xx xxxxxxxx xxx spotřebitele. X xxxxxxx xx xxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX kategorie 2 x xx stanovisko XXXX x xxxxxxxx x xxxx, že xxxxxx známa x xx xxxxxxxxxx XXXX xxxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xx xxxx xxxxx xxxx xxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx v příloze XXX xxxxxxxx (ES) x. 1223/2009 x xxxxxxxx na xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX uvedeného xxxxxxxx.

(9)

Xxxxx xxxxxxxxxxx je x xxxxxxxx xxxx xxxxxxx x xxxxxxx 13 xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx pro xxxxxxx xxxxx x xxxxxxxxxxx xx 5 % x xxxxxxxxx připraveném x xxxxxxx. X xxxxxxxx xxxx xx xxxx xxxxxxx x xxxxxxx 5 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xxxx látka povolená x xxxxxxxxxxx xxx ústní xxxxxxx x xxxxxxxxxxx do 0,1 % a v jiných xxxxxxxxxxx x xxxxxxxxxxx do 0,2 %. Xxxxxxxxxxx xxx klasifikován xxxx látka XXX xxxxxxxxx 1B xxxxxxxxx Xxxxxx (XX) č. 605/2014 (9). Xxxx xxxxxxxxxxx se xxxxx použitelnou dne 1. xxxxx 2016. V souladu x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxxx xxxxxxxx (ES) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 1 A xxxx 1X v kosmetických xxxxxxxxxxx výjimečně xxxxxxx, xxxxx xxxx xxxx, xx xxxx klasifikovány xxxx xxxxx CMR, xxxxxxx xxxxxx xxxxxxxx xxxxxx xxxxxxxx, že xxxxxx k dispozici xxxxx xxxxxx xxxxxxxxxxxx látky, xx xxxx xxxxxx xxxxxx na určité xxxxxxx xxxxxxxxx xxxxxxxxx xx známou expozicí x xx byla tato xxxxx XXXX xxxxxxxxxx x xxxxxxxx xxxx xxxxxxxx. Xxx 7. xxxxxxxxx 2014 dospěl XXXX xx svém xxxxxxxxxx (10) k závěru, že „xxx tvrzení nebo xxxxxxxx xxxxx xxxxx xxx xxxxxxxx xxxxxxx xxxxxxxxx pro tvrzení xxxxx x xxxxxxxx koncentraci xxxxxx 2,2 % volného xxxxxxxxxxxx“. Protože xxxx xxxxxx xxxxxxxxx, xx xxxxxx k dispozici xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxxxx xxxxx, xxx xx být xxxxxxxxxxx xxxxx xx xxxxxxx xxxxx podléhajících xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009. Xxxxxxxx k tomu, xx xxxxxx podána xxxxxx xx xxxx xxxxxxx xxxxxxxxxxxx, měla by xxx xxxx xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxxx xxxxxxxx. Formaldehyd xx xxx xxx xxxxxx xxxxxxx xx xxxxxx xxxxx zakázaných x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxx patří xxxx xxxxx xxxxxxxxxx xxxxxxx vodíku, které xxxx v současné xxxx xxxxxxx x xxxxxxx 12 xxxxxxx III xxxxxxxx (XX) č. 1223/2009. Xxxx xxxxx byly xxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 1X xxxxxxxxx (XX) x. 790/2009. Tato xxxxxxxxxxx se stala xxxxxxxxxxx xx dni 1. xxxxxxxx 2010. Na použití xxxxxx xxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxx xxxx xxxxxx xxxxxx x xxxxxxxxx xx. 15 odst. 2 xxxxxxx pododstavce xxxxxxxx (XX) x. 1223/2009. Xxx 22. xxxxxx 2010 dospěl XXXX xx xxxx xxxxxxxxxx (11) x xxxxxx, xx „obecná xxxxxxx platná xxx xxxxx, které xxxxxxxx xxxxxxx xxxxxx, by xx xxxx xxxxxxxxx xx xxxxxxxxxx sodný x xxxxxxxx xxxxxxxxxx a že xxxxxxx xxxxxxxxxxx xxxxxxx xxxx xxxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxx 3 % xx osobu xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx xxxxxxxxx, xx xxxxxx k dispozici xxxxx xxxxxx alternativní xxxxx xxx xxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx sodné xx xxxx xxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009 x xxxxxxxx xx seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II uvedeného xxxxxxxx.

(11)

Xxxxx jde x xxxxxx xxxxx, xxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX podle xxxxxxxx (XX) x. 1272/2008 a pro xxx xxxx xxxxxx xxxxxx o uplatnění xx. 15 xxxx. 1 xxxxx věty xxxxxxxx (XX) x. 1223/2009, xxxx xxxxxxxxx, xx xxxxxxxx xxxxxxxxx x xxxxxxxx xxxxxxxxxx xx splněna. Xx xx xxxx xxxxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx, Furfural a Polyaminopropyl xxxxxxxxx.

(12)

Xxxxx xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx, xxxxx xxxxx xxxxx XXXX zní Trimethylbenzoyl xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx v současné době xx příloh xxxxxxxx (XX) č. 1223/2009 xxxxxxxx. Xxxx xxxxx byla xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (XX) x. 618/2012 (12). Xxxx xxxxxxxxxxx xx stala xxxxxxxxxxx xxx 1. prosince 2013. Xxx 27. xxxxxx 2014 xxxxx XXXX xxxxxxx xxxxxxxxxx (13), x xxxx xxxxxx k závěru, xx xxxxx XXX je xxxxxxxx při použití xxxx přípravek k modeláži xxxxx v koncentraci xx 5,0 %, xxxxx xx xxx o látku xxxxx xxxxxxxxxxxxxxx xxxx. Xxxxxxxx x xxxxxxxxxxxxxxxx účinkům XXX xx xxxx a vysokému xxxxxx xxxxxxxx x xxxxxxxx xxxxx x xxxx při xxxxxxxx přípravku na xxxxx samotnými xxxxxxxxxxxx xx xxxxxxxxx XXX xxxx xxx xxxxxxx xx xxxxxxxxxxxxx xxxxxxxxx. X xxxxxxx xx xxxx xxxxxxxxxxx xx xxxxx XXX měla xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx III nařízení (XX) x. 1223/2009 xxx xxxxxxxxxxxxx xxxxxxx v systémech xxxxxxx xxxxx v koncentraci xxxxxxx 5 %.

(13)

Látka 2-xxxxxxxxxx, xxxxx xxxxx podle XXXX xxx Xxxxxxxx, xx xxxxxxx xxxx xxxxx xxxx xxxxxxxxxx xxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x x xxxxxxxx době xxxx xxxxxxxx xx xxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxx látka xxxx xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2 xxxxx xxxxxxxx (ES) x. 1272/2008. Xxxx klasifikace xx xxxxx xxxxxxxxxxx xxxx 1. prosincem 2010. Xxx 27. xxxxxx 2012 xxxxxx XXXX xx svém xxxxxxxxxx (14) x xxxxxx, xx xxxxxxx xxxxx Furfural x xxxxxxxxxxx do 10 xxx (0,001 %) x xxxxxxxxx xxxxxxxxxxx k použití, včetně xxxxxxxxx pro xxxxx xxxxxxx, xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxxxx Furfural jako xxxxx XXX kategorie 2 x xx xxxxxxxxxx XXXX xx látka Xxxxxxxx x xxxxxxxxxxx nejvýše 0,001 % xxxx xxx xxxxxxxx na xxxxxx xxxxx podléhajících omezení x xxxxxxx III xxxxxxxx (XX) č. 1223/2009.

(14)

Xxxxx polyhexamethylen-biguanid-hydrochlorid (XXXX), jejíž název xxxxx XXXX xxx Xxxxxxxxxxxxxxx xxxxxxxxx, je x xxxxxxxx době xxxxxxx xx seznamu jako xxxxxxxxxxx přísada x xxxxxxx 28 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 v koncentraci xxxxxxx 0,3 %. Tato xxxxx xxxx xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (XX) x. 944/2013 (15). Xxxx xxxxxxxxxxx xx xxxxx použitelnou xxx 1. xxxxx 2015. Xxx 18. června 2014 xxxxxx VVBS xxxxxxxxxx (16), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxxxxxxx údajů xxxxx látku XXXX xxxxxxxxx xx xxxxxxxxx xxx spotřebitele, xxxxx xx x xxxxxxxxxxx xxxxxxx 0,3 % xxxxxxx jako xxxxxxxxxxx xxxxxxx v jakémkoliv xxxxxxxxxxx přípravku. Ve xxxx xxxxxxxxxx xxxx XXXX xxxxxx xxxxxx x xxxxxx, že xxxxxxxx xxxxxxx xx xxxxx xxx xxxxxxxx xx xxxxx xxxxxxxxxxx xxxxxxx x/xxxx omezení, xxxxx xxx o kategorie kosmetických xxxxxxxxx, a že xxxx xxxxxxxxx studie dermální xxxxxxxx xxxxxxxx xx xxxxxxx xxxxxxxxxxxxxxxxx kosmetických xxxxxxxxx. Dne 7. xxxxx 2017 xxxxxx XXXX xxxx xxxxxxxxxx (17), ve kterém xxxxxx x xxxxxx, že xx xxxxxxx xxxxxxxxxxxx xxxxx se xxxxxxx XXXX xxxx xxxxxxxxxxx xxxxxxx ve xxxxx xxxxxxxxxxxx přípravcích v koncentraci xx 0,1 % xxxxxxxx xx bezpečné, ale xxxx použití xx xxxxxxxx xx xxxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx XXXX xxxx xxxxx XXX xxxxxxxxx 2 x xx xxxx xxxxxxxxxx XXXX by xxxxx XXXX xxxx být xxxxxxxx jako xxxxxxxxxxx xxxxxxx xx xxxxx xxxxxxxxxxxx přípravcích, x xxxxxxxx xxxxxxxx, jež mohou xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx xxxxxxxxxx, x xxxxxxxxxxx xxxxxxx 0,1 %. Podmínky xxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 by xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx změněny.

(15)

Xxxxx xxx x xxxxxx xxxxxxx xxxxx, xxxxx byly xxxxxxxxxxxxx xxxx látky CMR xxxxx xxxxxxxx (ES) x. 1272/2008, xxxxx xxxxxx xx xxxxxxxxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxx xxxxxxxxxx. Xxxx xxxxx xx xxxx xxx xxxxxxxx na xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009 a případně xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx látek v přílohách XXX a V uvedeného xxxxxxxx. Xx se xxxx xxxx jiné některých xxxxxxxxx xxxx, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009.

(16)

Některé xxxxxxxxxx xxxx, které xxxx v současné xxxx xxxxxxx v položkách 1x x 1x xxxxxxx III xxxxxxxx (XX) x. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx xxxx xxxxxxxxx (XX) č. 790/2009 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1X. Xxxx xxxxxxxxxxx xx stala xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxxx xxxxxxxx (ES) x. 1223/2009 xxxxx xxx látky xxxxxxxxxxxxx jako látky XXX xxxxxxxxx 1 A xxxx 1X x xxxxxxxxxxxx xxxxxxxxxxx výjimečně použity, xxxxx xxxx xxxx, xx byly klasifikovány xxxx xxxxx XXX, xxxxxxx xxxxxx xxxxxxxx. Xxx 22. xxxxxx 2010 vydal XXXX xxxxxxxxxx (18), x xxxx xxxxxx x xxxxxx, xx xxxxxxx xxxxxxxxxx xxxx, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx XXX xxxxxxxxx nařízení, xxxx pro xxxxxxx x xxxxxxxxxxxx přípravcích xx xxxxxxxx podmínek xxxxxxxx. Xxxxxxx xxxxxx podána xxxxxx xx xxxxxx xxxxxxx x xxxxxx stanoveno, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx účely xxxxxxxxxxxx použití xxxxxxxxx x xxxxxxx III xxxxxxxx (XX) x. 1223/2009, xxxx xx být xxxxxxx xxxxxxxxxx xxxx xxxxxx xx seznamu látek xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX uvedeného xxxxxxxx x xxxxxxxx xx xxxxxx xxxxx zakázaných x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX xxxxxxxx (XX) x. 1223/2009. Xxxxx xxx o dibutylcín-hydrogenborát, xxxxxx xxxxxx xxxxxx xx xxxxxx použití x XXXX xx xxxxxxxxx xxxx xxxxxxxxx. Xxxxxxx xxxxx by proto xxxx xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II xxxxxxxx (XX) x. 1223/2009.

(17)

Xxxxxxxxxx xx. 31 xxxx. 1 nařízení (ES) x. 1223/2009 xxxxxxx, že xxxxxxxxxxx-xx xxxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx přípravcích xxxxxxxxxxx riziko xxx xxxxxx zdraví, xxxxx xxxxxxxx kroky xx xxxxxx Xxxxxxxxxxxx, může Xxxxxx xx xxxxxxxxxx x XXXX odpovídajícím xxxxxxxx xxxxxx xxxxxxx XX xx VI uvedeného xxxxxxxx. Komise xxxxxxxxxxxx XXXX xxxxxxx xxxxxxxxxxx xxxxxxxx látek, xxxxx xxxx x xxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X, 1B xxxx 2. To xx xxxx xxxxxxxx xxxxxxxxx boru, xxxxx x xxxxx xxxxxxxxxxxxxxx a methylenglykol.

(18)

Některé xxxxxxxxxx boru, v současné xxxx uvedené x xxxxxxxxx 1x a 1b xxxxxxx XXX nařízení (XX) x. 1223/2009, jiné xxx xxxxxxxxxx xxxxxxx v 16. xxxx xxxxxxxxxx, xxxxxx xxxxxxxxxxxxx xxxx látky XXX. Xxx 12. xxxxxxxx 2013 xxxxx XXXX xxxxxxxxxx xxxxxxxx xx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx (19), xx xxxxxx xxxxxx x xxxxxx, xx se uvedené xxxxx, stejně jako xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx, xxxx xx XXX-xxxxx, XXXX-xxxxxxx, xxxxxxx draselný, xxxxxxxxxxxxxxx-xxxxx a boritan zinečnatý, xxxxxxxxx ve vodných xxxxxxxxx xx xxxxxxxx xxxxxxx, x xxxxx xx xx xxxxxx xxxxxxx xxxxxx xxx xxxxxxxx xxxxxxx měla xxxxxxxxx xx xxxxx xxxxxxx xxxxxxxx, tetraboritanů a oktaboritanů. Xxxxxxxx xxxxxx xxxx xxxxxxxxx (ES) č. 790/2009 xxxxxxxxxxxxx xxxx látka XXX kategorie 1X. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xx xxx 1. prosince 2010. Xxxx xxxxxxx boritanů, xxxxxxxxxxxxx x xxxxxxxxxxxx, s výjimkou látek x xxxxxxx xxxxxxx, xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx CMR, stejně xxxx xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx by xxxx xxx x xxxxxxx na xxxxxxxxxx VVBS xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení v příloze XXX nařízení (XX) x. 1223/2009 a doplněny xx xxxxxx látek zakázaných x xxxxxxxxxxxx přípravcích x xxxxxxx XX uvedeného xxxxxxxx.

(19)

Xxxxx xxxxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx xx xxxxxxx x xxxxxxx 5 xxxxxxx V nařízení (XX) x. 1223/2009, xxxxx na xxxxxx xx xxxxxxxxxxxx xxxxxx klasifikována jako xxxxx CMR. Xxxxx xxxxxxxxxxxxxx xxxx x xxxxxxxx xxxx xx xxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxxxxx. Xx dnech 26. a 27. června 2012 xxxxxx XXXX xxxxxxxxxx xxxxxxxx xx methylenglykolu (20), ve xxxxxx xxxxxxxx, xx xxxxxxxxxxxxxx xx xx xxxx xxxxxxx podmínek xxxxxx reverzibilní, xxx xxxx x xxxx xxxxxxx xx xxxxxxxxxxx ve xxxxxxx xxxxxxxxx, x xx xxxxxxxxxxxxxxx může depolymerizovat, xxx xxxx x xxxx xxxxxxx xx formaldehyd xxxxxxxx nebo xxxxxxx. X xxxxxxx xx xxxxxxxxxx XXXX xxxxxxxx potenciální xxxxxx xxx xxxxxx xxxxxx vyplývající z použití xxxxxx látek x xxxxxxxxxxxx xxxxxxxxxxx. Xxxxxxxxxxxxxxx by xxxxx xxx být xxxxx ze xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxx (ES) č. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx by xxxx xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX uvedeného xxxxxxxx.

(20)	Xxxxxxxx (XX) č. 1223/2009 xx xxxxx xxxx xxx odpovídajícím způsobem xxxxxxx.

(21)	Xxxxxxxx xxxxxxxxx tímto xxxxxxxxx xxxx v souladu xx xxxxxxxxxxx Stálého xxxxxx xxx xxxxxxxxxx xxxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx 1

Xxxxxxx II, III x X xxxxxxxx (ES) x. 1223/2009 xx xxxx v souladu x xxxxxxxx tohoto xxxxxxxx.

Xxxxxx 2

Xxxx nařízení xxxxxxxx x xxxxxxxx dvacátým xxxx xx xxxxxxxxx x Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxx xxxxxxxx xx xxxxxxx v celém rozsahu x xxxxx použitelné ve xxxxx xxxxxxxxx xxxxxxx.

X Xxxxxxx xxx 22. xxxxxx 2019.

Xx Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;342, 22.12.2009, s. 59.

(2)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx dne 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX a o změně xxxxxxxx (XX) x.&xxxx;1907/2006 (Úř. věst. L 353, 31.12.2008, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) 2017/776 xx xxx 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku mění xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;116, 5.5.2017, x.&xxxx;1).

(4)&xxxx;&xxxx;Xxxxxxxx Komise (ES) x.&xxxx;790/2009 xx xxx 10.&xxxx;xxxxx&xxxx;2009, xxxxxx xx xxx xxxxx přizpůsobení xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;235, 5.9.2009, x.&xxxx;1).

(5)&xxxx;&xxxx;XXXX/1344/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_077.pdf.

(6)&xxxx;&xxxx;XXXX/1360/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_053.xxx.

(7)&xxxx;&xxxx;XXXX/1408/11, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_118.xxx

(8)&xxxx;&xxxx;XXXX/1547/15, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_170.pdf

(9) Nařízení Xxxxxx (XX) x.&xxxx;605/2014 xx xxx 5.&xxxx;xxxxxx&xxxx;2014, xxxxxx xx xxx xxxxx zařazení xxxxxxxxxxxx xxxxxx xxxxxxxxxx xx nebezpečnosti x&xxxx;xxxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxxx mění xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Úř. věst. L 167, 6.6.2014, x.&xxxx;36).

(10)&xxxx;&xxxx;XXXX/1538/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_164.xxx

(11)&xxxx;&xxxx;XXXX/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;618/2012 xx xxx 10.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx se xxx xxxxx přizpůsobení xxxxxxx-xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;179, 11.7.2012, x.&xxxx;3).

(13) SCCS/1528/14, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_149.xxx.

(14)&xxxx;&xxxx;XXXX/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15) Nařízení Xxxxxx (EU) x.&xxxx;944/2013 xx xxx 2.&xxxx;xxxxx&xxxx;2013, kterým xx xxx xxxxx přizpůsobení xxxxxxxxxxxxxxxxxx xxxxxxx mění xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;261, 3.10.2013, s. 5).

(16)&xxxx;&xxxx;XXXX/1535/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_157.xxx

(17)&xxxx;&xxxx;XXXX/1581/16, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxx/xxxxxx/xxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_204.xxx

(18)&xxxx;&xxxx;XXXX/1249/09, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_027.xxx

(19)&xxxx;&xxxx;XXXX/1523/13, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_146.xxx

(20)&xxxx;&xxxx;XXXX/1483/12, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_097.pdf

PŘÍLOHA

Příloha II xx xxxx xxxxx:

xxxxxxxx se xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx látky
Xxxxxxxxxx xxxxx	Chemický xxxxx/XXX	Xxxxx XXX	Xxxxx XX
x	x	x	x
„1385	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX)	51229-78-8	426-020-3
1386	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX), xxxxxxxxxx-15	51229-78-8	426-020-3
1387	2-Xxxxxxxxxxxxx	79-07-2	201-174-2
1388	Xxxxxxxxxxxxxxxxxxxxxxxxxxx	556-67-2	209-136-7
1389	Xxxxxxxxxxxxx; xxxxxxxxxxxxxxx	75-09-2	200-838-9
1390	2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx	85954-11-6	413-900-7
1391	Xxxxxxxxxxx; ethanal	75-07-0	200-836-8
1392	1-Cyklopropyl-6,7-difluor-4-oxo-1,4-dihydrochinolin-3-karboxylová xxxxxxxx	93107-30-3	413-760-7
1393	X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx	872-50-4	212-828-1
1394	Xxxxxxxxxxxx; xxxx boritý	1303-86-2	215-125-8
1395	Kyselina xxxxxx [1] Kyselina boritá [2]	10043-35-3 [1] 11113-50-1 [2]	233-139-2 [1] 234-343-4 [2]
1396	Boritany, xxxxxxxxxxxxx, xxxxxxxxxxxx x xxxx x xxxxxx kyseliny xxxxxx, včetně:
	Oktaboritan xxxxxxx xxxxxxxxxxx [1]	12280-03-4 [1]	234-541-0 [1]
	2-xxxxxxxxxxxx, xxxxxxxxx x xxxxxxxxx xxxxxxx [2]	10377-81-8 [2]	233-829-3 [2]
	(2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxxxxxxx [3]	68003-13-4 [3]	268-109-8 [3]
	Xxxxxxx xxxxxxxx, xxxxxxxx sůl xxxxxxxx xxxxxx [4]	12712-38-8 [4]	603-184-6 [4]
	Xxxxxxxxxxxxxxx-xxxxx [5]	-[5]	— [5]
	Boritan xxxxxxxxx [6]	1332-07-6 [6]	215-566-6 [6]
	Xxxxxxx xxxxx, xxxxxxxxxxxx xxxxxxx xxxxxxx; xxxxx xxx xxxxxxxx borité [7]	1330-43-4 [7]	215-540-4 [7]
	Heptaoxid xxxxxxx-xxxxxxxxxxx hydrát [8]	12267-73-1 [8]	235-541-3 [8]
	Xxxxx xxx xxxxxxxx xxxxxxxxxxx [9]	13840-56-7 [9]	237-560-2 [9]
	Xxxxxxxxxxxx xxxxxxx xxxxxxxxxx; xxxxx xxxxxxxxxx [10]	1303-96-4 [10]	215-540-4 [10]
	Xxxxxxxxxxxx xxxxxxx pentahydrát; xxxxx xxxxxxxxxxx [11]	12179-04-3 [11]	215-540-4 [11]
1397	Xxxxxxxxxx xxxxx [1] xxxxxxxxxxxxxxxxx xxxxx; peroxoboritan xxxxx [2]	15120-21-5 [1]	239-172-9 [1]
1397		7632-04-4 [2] 10332-33-9 [2] 10486-00-7[2]	231-556-4 [2]
1398	Xxxxxxxx xxxxxxxxx (X3XX2(X2)), xxxxxxxxx xxx, xxxxxxxxx [1]	13517-20-9 [1]	239-172-9 [1]
	xxxxxxxx perboritá, xxxxx xxx, xxxxxxxxxxx [2]	37244-98-7 [2]	234-390-0 [2]
	xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, xxxxxxxxxxx xxxxxxxxxxxxx xxxxx xxxxxxxxxx [3]	10486-00-7 [3]	231-556-4 [3]
1399	Xxxxxxxx perboritá, xxxxx xxx [1]	11138-47-9 [1]	234-390-0 [1]
	xxxxxxxx xxxxxxxxx, xxxxx sůl, monohydrát [2]	12040-72-1 [2]	234-390-0 [2]
	kyselina xxxxxxxxx (XXX(X2)), xxxxx xxx, xxxxxxxxxx [3]	10332-33-9 [3]	231-556-4 [3]
1400	Xxxxxxxxxx-xxxxxxxxxxxxx	75113-37-0	401-040-5
1401	Xxxxxxxxxxxxxxxxxx xxxxxxxxx	14708-14-6	238-753-4
1402	Xxxxxxxx (XXX); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx), polymerní xxxxxxx xx zinečnatou xxxx	8018-01-7	616-995-5
1403	Xxxxx (XXX); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx) (xxxxxxxxx)	12427-38-2	235-654-8
1404	Xxxxxxxxxxx (XXX); ethyl-N-[({[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]karbonyl} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx	82560-54-1	617-356-3
1405	X-xxxxxxxx-X-xxxxxx karbonylthiokarbamát	103122-66-3	434-350-4
1406	Chlorprofam (XXX); xxxxxxxxx-3-xxxxxxxxxxxxxxx	101-21-3	202-925-7
1407	Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx	109202-58-6	432-750-3
1408	Xxxxxxxxxxxxxxx-xxxxxx	13465-08-2	236-691-2
1409	(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx	105024-66-6	405-020-7
1410	Xxxxx (ISO); diethyl-N-[fenyl(kyan)methyl]fosforamidát	14816-18-3	238-887-3
1411	Glufosinát xxxxxx (ISO); amonium-2-amino-4-[hydroxy (xxxxxx)xxxxxxxx]xxxxxxxx	77182-82-2	278-636-5
1412	Xxxxxxx xxxx: xxxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxx-xxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx	—	435-960-3
1413	(4-Xxxxxxxxxx)xxxxxxxxx xxxxxxxx	86552-32-1	420-450-5
1414	Xxxxxxx xxxx: 4,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 4,8-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx	170016-25-8	427-050-1
1415	Xxxxxxxxxxx xxxxxxxxxx-xxxxxxxxxxxxxx(X2Xx6X13)	12056-51-8	432-240-0
1416	Xxxxx xxxxxxxxxx	71-48-7	200-755-8
1417	Xxxxxxxx xxxxxxxxxx	10141-05-6	233-402-1
1418	Xxxxxxxxx kobaltnatý	513-79-1	208-169-4
1419	Chlorid xxxxxxxxx	7718-54-9	231-743-0
1420	Xxxxxxxx xxxxxxxxx [1]	13138-45-9 [1]	236-068-5 [1]
1420	xxxxxxxx xxxxxxx, xxx xxxxx [2]	14216-75-2 [2]	238-076-4 [2]
1421	Xxxxxxx xxxxxxx (lech)	69012-50-6	273-749-6
1422	Bahna x xxxx x xxxxxxxxxxxxxx rafinace mědi, xxxxxxx xxxx, x xxxxxxx xxxxxx nikelnatého	92129-57-2	295-859-3
1423	Bahna x xxxx x xxxxxxxxxxxxxx xxxxxxxx xxxx, xxxxxxx xxxx	94551-87-8	305-433-1
1424	Xxxxxxxxxx nikelnatý; xxxxxxxx xxxxxxxxx, nikelnatá xxx	13637-71-3	237-124-1
1425	Xxxxx didraselno-nikelnatý [1]	13842-46-1 [1]	237-563-9 [1]
1425	xxxxx diamonno-nikelnatý [2]	15699-18-0 [2]	239-793-2 [2]
1426	Nikl-bis(sulfamidát); xxxx-xxxxxxxx	13770-89-3	237-396-1
1427	Xxxxxxxxxxxxxxxxxx xxxxxxxxx	14708-14-6	238-753-4
1428	Xxxx-xxxxxxxxx [1]	3349-06-2 [1]	222-101-0 [1]
	xxxxxxxx xxxxxxxx, xxx xxxxx [2]	15843-02-4 [2]	239-946-6 [2]
	xxxxxxxx xxxxxxxx, xxx xxxx x xxxxx [3]	68134-59-8 [3]	268-755-0 [3]
1429	Xxxx-xxxxxxxx [1]	373-02-4 [1]	206-761-7 [1]
1429	xxxx-xxxxxx [2]	14998-37-9 [2]	239-086-1 [2]
1430	Xxxx(XX)-xxxxxxxxx	553-71-9	209-046-8
1431	Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)	3906-55-6	223-463-2
1432	Xxxx(XX)-xxxxxxx; xxxx(XX)-xxxxxxx	2223-95-2	218-744-1
1433	Xxxx-xxxxxxxx	16039-61-5	—
1434	Xxxx(XX)-xxxxxxxx	4995-91-9	225-656-7
1435	Xxxxxxx xxxxxxxxx [1]	10028-18-9 [1]	233-071-3 [1]
	xxxxxx xxxxxxxxx [2]	13462-88-9 [2]	236-665-0 [2]
	xxxxx xxxxxxxxx [3]	13462-90-3 [3]	236-666-6 [3]
	xxxxxxx xxxxxxxx-xxxxxxxxx [4]	11132-10-8 [4]	- [4]
1436	Xxxxxxxxxxxxxxxxxxxx xxxxxxxxx	26043-11-8	247-430-7
1437	Xxxxxxx xxxxxxxxx	15060-62-5	239-125-2
1438	Xxxxxxxxxxxxxxxxxxx nikelnatý [1]	14332-34-4 [1]	238-278-2 [1]
	bis(dihydrogenfosforečnan) xxxxxxxxx [2]	18718-11-1 [2]	242-522-3 [2]
	xxxxxxxxxxxxxxxx nikelnatý [3]	10381-36-9 [3]	233-844-5 [3]
	xxxxxxxxxxxxx dinikelnatý [4]	14448-18-1 [4]	238-426-6 [4]
	xxx(xxxxxxxxx) xxxxxxxxx [5]	14507-36-9 [5]	238-511-8 [5]
	xxxxxxxxxxxx xxxxx [6]	36026-88-7 [6]	252-840-4 [6]
	xxxxxxxx xxxxxxxxxx, xxx vápníku x xxxxx [7]	17169-61-8 [7]	- [7]
	xxxxxxxx xxxxxxxxxxxx, xxxxxxxxx xxx [8]	19372-20-4 [8]	— [8]
1439	Xxxxxxxxxxxxxxxxxxxxx diamonno-nikelnatý	74195-78-1	—
1440	Kyanid nikelnatý	557-19-7	209-160-8
1441	Chroman xxxxxxxxx	14721-18-7	238-766-5
1442	Xxxxxxxxxx xxxxxxxxx [1]	21784-78-1 [1]	244-578-4 [1]
	xxxxxxxxxxxxxxx xxxxxxxxxxx [2]	13775-54-7 [2]	237-411-1 [2]
	xxxxxxxxxx xxxxxxxxx (3:4) [3]	31748-25-1 [3]	250-788-7 [3]
	xxxxxxxx křemičitá, xxx niklu [4]	37321-15-6 [4]	253-461-7 [4]
	xxxxxxxxxxx-xxxxxxxxxx [xxxxxxxxxxxxx(4-)]xxxxxxxxxxxx(3-)xxxxxxxx [5]	12519-85-6 [5]	235-688-3 [5]
1443	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxx	14874-78-3	238-946-3
1444	Xxxxxxxxxxxxx trinikelnatý; arseničnan xxxxxxxxx	13477-70-8	236-771-7
1445	Xxxx(XX)-xxxxxx [1]	547-67-1 [1]	208-933-7 [1]
1445	xxxxxxxxx xxxxxxxx, xxx xxxxx [2]	20543-06-0 [2]	243-867-2 [2]
1446	Xxxxxxxx xxxxxxxxx	12142-88-0	235-260-6
1447	Xxxxxxxxxxx xxxxxxxx	12137-12-1	—
1448	Xxxxxxxxxxxx xxxxxxxxxxxx	74646-29-0	—
1449	Xxxx xxxxxxxx s xxxxxxx xxxxx a xxxxxxx; X.X. pigmentová xxxx 25; C.I. 77332 [1]	68186-89-0 [1]	269-051-6 [1]
	xxxxxx xxxxxxxxxx-xxxxxxxxx [2]	58591-45-0 [2]	261-346-8 [2]
	oxid kobaltu x xxxxx [3]	12737-30-3 [3]	620-395-9 [3]
1450	Trioxid xxxxxxxxx-xxxxxxxx; xxxxxxxxx xxxxxxxxx	12035-38-0	234-824-9
1451	Xxxxxxxx nikelnato-triuranový	15780-33-3	239-876-6
1452	Dithiokyanatan xxxxxxxxx	13689-92-4	237-205-1
1453	Xxxxxxxxx xxxxxxxxx	15586-38-6	239-646-5
1454	Xxxxxxxxxxx nikelnatý	10101-96-9	233-263-7
1455	Selenid xxxxxxxxx	1314-05-2	215-216-2
1456	Xxxxxxxx xxxxxxxxx, xxx xxxxx x xxxxx	68130-19-8	—
1457	Xxxxxxxxx xxxxx [1]	12068-61-0 [1]	235-103-1 [1]
1457	xxxxxxx xxxxx [2]	27016-75-7 [2]	248-169-1 [2]
1458	Xxxxxx xxxxx xxxxxxxx s xxxxxxx xxxxx, xxxxx x xxxxxx; X.X. xxxxxxxxxx xxxx 157; X.X. 77900	68610-24-2	271-853-6
1459	Xxxxxxxxxx xxxxxxxxx [1]	67952-43-6 [1]	267-897-0 [1]
	bromičnan xxxxxxxxx [2]	14550-87-9 [2]	238-596-1 [2]
	xxxxx-xxxxxxxx-xxxxxx, xxxxxxxxx xxx [3]	71720-48-4 [3]	275-897-7 [3]
1460	Nikl(II)-trifluoracetát [1]	16083-14-0 [1]	240-235-8 [1]
	xxxx(XX)-xxxxxxxxx [2]	3349-08-4 [2]	222-102-6 [2]
	nikl-bis(benzensulfonát) [3]	39819-65-3 [3]	254-642-3 [3]
	xxxx(XX)-xxxxxxxx-xxxxxx [4]	18721-51-2 [4]	242-533-3 [4]
	citronová xxxxxxxx, xxxxxxxxxxxxxxx xxx [5]	18283-82-4 [5]	242-161-1 [5]
	xxxxxxxxx kyselina, xxx xxxxx [6]	22605-92-1 [6]	245-119-0 [6]
	xxxx-[xxx(2-xxxxxxxxxxxxx)] [7]	4454-16-4 [7]	224-699-9 [7]
	2-xxxxxxxxxxxxx xxxxxxxx, xxx xxxxx [8]	7580-31-6 [8]	231-480-1 [8]
	xxxxxxxxxxxxxxxx kyselina, xxx niklu [9]	93983-68-7 [9]	301-323-2 [9]
	xxxx(XX)-xxxxxxxxxxx [10]	29317-63-3 [10]	249-555-2 [10]
	isooktanová xxxxxxxx, xxx niklu [11]	27637-46-3 [11]	248-585-3 [11]
	xxxx-xxxxxxxxxxxxx [12]	84852-37-9 [12]	284-349-6 [12]
	xxxx(XX)-xxxxxxxxxxx [13]	93920-10-6 [13]	300-094-6 [13]
	nikl(II)-isodekanoát [14]	85508-43-6 [14]	287-468-1 [14]
	xxxx(XX)-xxxxxxxxxxx [15]	85508-44-7 [15]	287-469-7 [15]
	xxxxxxxxxxx xxxxxxxx, xxx xxxxx [16]	51818-56-5 [16]	257-447-1 [16]
	xxxx(XX)-xxxxxxxxxxxxx [17]	93920-09-3 [17]	300-093-0 [17]
	xxx(X-xxxxxxxxx-X 1,O 2)xxxx [18]	71957-07-8 [18]	276-205-6 [18]
	xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]	52625-25-9 [19]	258-051-1 [19]
	nikl(II)-palmitát [20]	13654-40-5 [20]	237-138-8 [20]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [21]	85508-45-8 [21]	287-470-2 [21]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [22]	85508-46-9 [22]	287-471-8 [22]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [23]	84852-35-7 [23]	284-347-5 [23]
	(2-ethylhexanoato-O)(isodekanoato-O)nikl [24]	84852-39-1 [24]	284-351-7 [24]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]	85135-77-9 [25]	285-698-7 [25]
	(isodekanoato-O)(isooktanoato-O)nikl [26]	85166-19-4 [26]	285-909-2 [26]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [27]	84852-36-8 [27]	284-348-0 [27]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [28]	85551-28-6 [28]	287-592-6 [28]
	xxxxxx xxxxxxxx, X6-19 xxxxxxxxxx, xxxx xxxxx [29]	91697-41-5 [29]	294-302-1 [29]
	xxxxxx kyseliny, X8-18 x nenasycené X18, xxxx xxxxx [30]	84776-45-4 [30]	283-972-0 [30]
	naftalen-2,7-disulfonová kyselina, xxxxxxxxx sůl [31]	72319-19-8 [31]	[31]
1461	Xxxxxxxxx xxxxxxxxx [1]	7757-95-1 [1]	231-827-7 [1]
	xxxxxxx xxxxxxxxx-xxxxxxxxxxx [2]	15851-52-2 [2]	239-967-0 [2]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxx [3]	15852-21-8 [3]	239-974-9 [3]
	xxxxxxxxxxx-xxxxxxxx-xxxx xxxxxxxxx a xxxxx [4]	68130-36-9 [4]	268-585-7 [4]
1462	Xxxxx xxxxx (XxX) [1]	12007-00-0 [1]	234-493-0 [1]
	borid xxxxxxx [2]	12007-01-1 [2]	234-494-6 [2]
	xxxxx triniklu [3]	12007-02-2 [3]	234-495-1 [3]
	xxxxx xxxxx [4]	12619-90-8 [4]	235-723-2 [4]
	xxxxxxx xxxxxxxxx [5]	12059-14-2 [5]	235-033-1 [5]
	xxxxxxxxx xxxxx [6]	12201-89-7 [6]	235-379-3 [6]
	xxxxxx xxxxxxx [7]	12035-64-2 [7]	234-828-0 [7]
	xxxxxx xxxxx x xxxx [8]	65229-23-4 [8]	[8]
1463	Xxxxxxxxx nikelnato-dihlinitý [1]	12004-35-2 [1]	234-454-8 [1]
	trioxid xxxxxxxxx-xxxxxxxxxx [2]	12035-39-1 [2]	234-825-4 [2]
	xxxx niklu a xxxxxx [3]	12653-76-8 [3]	235-752-0 [3]
	xxxxxxxx nikelnato-divanadičný [4]	52502-12-2 [4]	257-970-5 [4]
	oktaoxid kobaltnato-nikelnato-dimolybdenový [5]	68016-03-5 [5]	268-169-5 [5]
	xxxxxxx xxxxxxxxx-xxxxxxxxxxx [6]	70692-93-2 [6]	274-755-1 [6]
	xxxxxxxxx nikelnato-molybdenový [7]	14177-55-0 [7]	238-034-5 [7]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxx [8]	14177-51-6 [8]	238-032-4 [8]
	xxxxxx, xxxxxxx zeleň [9]	68515-84-4 [9]	271-112-7 [9]
	xxxxxx dilithno-nikelnatý [10]	12031-65-1 [10]	620-400-4 [10]
	oxid xxxxxxxxx x xxxxx [11]	12673-58-4 [11]	— [11]
1464	Xxxxxx-xxxxxxx-xxxx-xxxx	—	442-750-5
1465	Xxxx xxxxxxxxxxx	1313-27-5	215-204-7
1466	Xxxxxxxxxxxxxxxxxxx (XXXX)	683-18-1	211-670-0
1467	4,4′-xxx(X-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxxxxxx) xxxxxxxxxxxxx	151882-81-4	418-770-5
1468	Xxxxxxxxxxxxxxx; (2-xxxxx)xxxxxxxx	98-00-0	202-626-1
1469	1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-vinylcyklohexendiepoxid	106-87-6	203-437-7
1470	6-Glycidyloxynaft-1-yl-oxymethyloxiran	27610-48-6	429-960-2
1471	2-(2-Aminoethylamino)ethanol (XXXX)	111-41-1	203-867-5
1472	1,2-Xxxxxxxxxxxxx	629-14-1	211-076-1
1473	(2,3-Xxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx	3033-77-0	221-221-0
1474	1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx	214353-17-0	433-580-2
1475	(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx	82413-20-5	428-010-4
1476	4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx	13595-25-0	428-970-4
1477	2-Xxxxx-6-xxxxxxxxxx	2040-90-6	433-890-8
1478	5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx	—	444-970-7
1479	2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx	94723-86-1	425-150-8
1480	Xxxxxxxxxx (XXX); 2-{(XX)-1-[(2XX)-2-(4-xxxxxxxxxxxx) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx	139001-49-3	604-105-8
1481	Xxxxxxxxxxxx (XXX); (RS)-(EZ)-2-{1-[(2E)-3-chlorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyklohex-2-en-1-on	149979-41-9	604-715-4
1482	3,3-(Ethylendioxy)estra-5(10),9(11)-dien-17-on	5571-36-8	427-230-8
1483	Androsta-1,4,9(11)-trien-3,17-dion	15375-21-0	433-560-3
1484	Reakční xxxx: kalcium-alkylsalicyláty (rozvětvené xxxxxx X10-X14 a X18-X30); kalcium-alkylfenoláty (xxxxxxxxxx xxxxxx C10-C14 x X18-X30); xxxxxxx-xxxxxxxxxxxxxxxxxxx (xxxxxxxxxx xxxxxx X10-X14 x X18-X30)	—	415-930-6
1485	Xxxxxxxx 1,2-benzendikarboxylová; xxxxxxx-(xxxxxx X6-X8)xxxxxx, rozvětvené, xxxxxx xx X7	71888-89-6	276-158-1
1486	Xxxxxxx xxxx: xxxxxxx 4,4′-xxxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] a xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:2); xxxxxxxx 4,4′-xxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] x xxxxxxxx 6-diazo-5,6-dihydro-5-oxonaftalen-1-sulfonové (1:3)	—	427-140-9
1487	Xxxxxxxxx 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx	150202-11-2	422-670-7
1488	Xxxxxxxx 3-xxxxxxxxxx-4-xx-17-β -xxxxxxxxxxx	302-97-6	414-990-0
1489	Xxxxxxxx (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx	64485-90-1	431-520-1
1490	Xxxxxxxxxx-xxxxxxxxxxxxxxxx	5064-31-3	225-768-6
1491	2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)	7425-14-1	231-057-1
1492	Xxxxxxxxxx-xxxxxx	84-69-5	201-553-2
1493	Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx; xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxx xxxxxxxx [1]	1763-23-1 [1]	217-179-8 [1]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx; kalium-heptadekafluoroktan-1-sulfonát [2]	2795-39-3 [2]	220-527-1 [2]
	xxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]	70225-14-8 [3]	274-460-8 [3]
	amonium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [4]	29081-56-9 [4]	249-415-0 [4]
	lithium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]	29457-72-5 [5]	249-644-6 [5]
1494	Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]	103112-35-2	401-290-5
1495	1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx	158894-67-8	422-900-6
1496	1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx	99464-83-2	444-950-8
1497	6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)	—	441-550-5
1498	Xxxxxxxxxxx (XXX); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidin; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx	1582-09-8	216-428-8
1499	4-Xxxxx-2-xxxxxxxxxxx	1671-49-4	430-550-0
1500	Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx	221354-37-6	432-270-4
1501	Xxxxxxx směs: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; xxxxxxxxx-3-({4-[(7-xxxxx-1-xxxxxxx-3-xxxxx-2-xxxxxx)xxx]-2,5-xxxxxxxxxxxxx}xxx)xxxxxxx	163879-69-4	438-310-7
1502	X,X′-(xxxxxxx-4,4′-xxxx)xxxxxxxxxxx	613-35-4	210-338-2
1503	Xxxxxxxxxxxxxx	108-91-8	203-629-0
1504	Xxxxxxxxx	110-85-0	203-808-3
1505	Xxxxxxxxxxxx	7803-49-8	232-259-2
1506	Xxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxx-xxxxxxxxxxxx [1]	5470-11-1 [1]	226-798-2 [1]
1506	bis(hydroxylamonium-sulfát); xxxxxxxxxxxx-xxxxxx (2:1) [2]	10039-54-0 [2]	233-118-8 [2]
1507	Xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxxx	—	—
1508	Xxxxxxxxxxx; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx	110235-47-7	600-951-7
1509	Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; hydroxylamin-sulfát (1:1) [1]	10046-00-1 [1]	233-154-4 [1]
	xxxxxxxxxxxx-xxxxxx [2]	20845-01-6 [2]	244-077-0 [2]
	xxxxxxxxxxxx-xxxxxxxxxxxxxxxx [3]	19098-16-9 [3]	242-818-2 [3]
	xxxxxxxxxxxx-4-xxxxxxxxxxxx-1-xxxxxxxx [4]	53933-48-5 [4]	258-872-5 [4]
1510	(3-Xxxxx-2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx	3327-22-8	222-048-3
1511	Xxxxxxx-3,3′,4,4′-xxxxxxxx; 3,3′-xxxxxxxxxxxxxxx	91-95-2	202-110-6
1512	Xxxxxxxxx-xxxxxxxxxxxx [1]	6094-40-2 [1]	228-042-7 [1]
	xxxxxxxxx-xxxxxxxxxxxxxx [2]	142-64-3 [2]	205-551-2 [2]
	xxxxxxxxx-xxxxxx [3]	1951-97-9 [3]	217-775-8 [3]
1513	3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx	87691-88-1	421-310-6
1514	(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx	19398-06-2	421-460-2
1515	(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx	40722-80-3	429-740-6
1516	4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx	159939-85-2	425-030-5
1517	Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx	3724-43-4	425-970-6
1518	7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;	199327-61-2	429-400-7
1519	Xxxxxxxx xxxxxx bis(2-hydroxypropyl) xxxxx x formaldehydem (1:4)	220444-73-5	432-440-8
1520	3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx	202197-26-0	445-590-4
1521	Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx	1239-45-8	214-984-6
1522	(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx	144177-62-8	447-860-7
1523	9-Xxxxxxxxxxxxx-3-xxxx; (9-Xxxxxxxxxxxxx-3-xx)xxxx	132-32-1	205-057-7
1524	(6X-xxxxx)-1-((7-xxxxxx-2-xxxxxxxxxxx-8-xxx-5-xxxx-1-xxxxxxxxxx-[4.2.0]xxx-2-xx-3-xx)xxxxxx)xxxxxxxxxx-xxxxx	100988-63-4	423-260-0
1525	Xxxxxxxxxxxxxxx (XXX); 1-(2-xxxxx-4-xxxxxxx)-3-xxxxxxxxxxxxx	68157-60-8	614-346-0
1526	1,3-Xxxxxxxxxxxxxxxxxxxxxxxxxxx-2(1X)-xx; xxxxxxxxxxxxxxxxxxxxxxxx	7226-23-5	230-625-6
1527	Xxxxxxxx	91-22-5	202-051-6
1528	Xxxxxxxxxxx; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} fenyl)piperazin-1-yl]ethan-1-on	65277-42-1	265-667-4
1529	Metkonazol (XXX); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx	125116-23-6	603-031-3
1530	Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx	183196-57-8	418-260-2
1531	1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx	26157-73-3	435-010-8
1532	2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (XXX)	52234-82-9	257-765-0
1533	4,4′-Xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]	101-68-8 [1]	202-966-0 [1]
	2,2′-xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]	2536-05-2 [2]	219-799-4 [2]
	x-(x-xxxxxxxxxxxxxxxx)xxxxx xxxxxxxxx; xxxxxxxxxxxxx-2,4′-xxxxxxxxxxx [3]	5873-54-1 [3]	227-534-9 [3]
	xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]	26447-40-5 [4]	247-714-0 [4]
1534	Xxxxxxx xxxxx (XXX); ethyl-(Z)-2-chlor-3-[2-chlor-5-(cyklohex-1-en-1,2-dikarboximido)fenyl]akrylát	142891-20-1	604-318-6
1535	N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamid	84245-12-5	424-550-1
1536	Dimoxystrobin (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx	149961-52-4	604-712-8
1537	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx	27366-72-9	435-470-1
1538	Xxxxxxx xxxx: 2,2′-[(3,3′-dichlorbifenyl-4,4′-diyl)bisazo]bis[N-(2,4-dimethylfenyl)-3-oxobutanamid]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-xxxxxxx-4′-[[1[[(2,4-xxxxxxxxxxxxx)xxxxx]xxxxxxxx]-2-xxxxxxxxx]xxx][1,1′-xxxxxxx]-4-xx]xxx]-X-(2-xxxxxxxxxxxxx)-3-xxx-xxxxxxxxx		434-330-5
1539	Xxxx, uhlí, xxxxx x zemní xxxx x xxxxxx xxxxxxxx generované xx xxxxxxx destilace a/nebo xxxxxx metod xxxxxxxxxx, xxxxx obsahují ≥ 0,1 % hmotnostních xxxxxxx	85536-20-5 85536-19-2 90641-12-6 90989-38-1 91995-20-9 92062-36-7 91995-61-8 101316-63-6 93821-38-6 90641-02-4 101316-62-5 90641-03-5 65996-79-4 101794-90-5 90640-87-2 84650-03-3 65996-82-9 90641-01-3 65996-87-4 90640-99-6 68391-11-7 92062-33-4 91082-52-9 68937-63-3 92062-28-7 92062-27-6 91082-53-0 91995-31-2 91995-35-6 91995-66-3 122070-79-5 122070-80-8 65996-78-3 94114-52-0 94114-53-1 94114-54-2 94114-56-4 94114-57-5 90641-11-5 8006-61-9 8030-30-6 8032-32-4 64741-41-9 64741-42-0 64741-46-4 64742-89-8 68410-05-9 68514-15-8 68606-11-1 68783-12-0 68921-08-4 101631-20-3 64741-64-6 64741-65-7 64741-66-8 64741-70-4 64741-84-0 64741-92-0 68410-71-9 68425-35-4 68527-27-5 91995-53-8 92045-49-3 92045-55-1 92045-58-4 92045-64-2 101316-67-0 64741-54-4 64741-55-5 68476-46-0 68783-09-5 91995-50-5 92045-50-6 92045-59-5 92128-94-4 101794-97-2 101896-28-0 64741-63-5 64741-68-0 68475-79-6 68476-47-1 68478-15-9 68513-03-1 68513-63-3 68514-79-4 68919-37-9 68955-35-1 85116-58-1 91995-18-5 93571-75-6 93572-29-3 93572-35-1 93572-36-2 64741-74-8 64741-83-9 67891-79-6 67891-80-9 68425-29-6 68475-70-7 68603-00-9 68603-01-0 68603-03-2 68955-29-3 92045-65-3 64742-48-9 64742-49-0 64742-73-0 68410-96-8 68410-97-9 68410-98-0 68512-78-7 85116-60-5 85116-61-6 92045-51-7 92045-52-8 92045-57-3 92045-61-9 92062-15-2 93165-55-0 93763-33-8 93763-34-9 64741-47-5 64741-48-6 64741-69-1 64741-78-2 64741-87-3 64742-15-0 64742-22-9 64742-23-0 64742-66-1 64742-83-2 64742-95-6 68131-49-7 68477-34-9 68477-50-9 68477-53-2 68477-55-4 68477-61-2 68477-89-4 68478-12-6 68478-16-0 68513-02-0 68516-20-1 68527-21-9 68527-22-0 68527-23-1 68527-26-4 68603-08-7 68606-10-0 68783-66-4 68919-39-1 68921-09-5 85116-59-2 86290-81-5 90989-42-7 91995-38-9 91995-41-4 91995-68-5 92045-53-9 92045-60-8 92045-62-0 92045-63-1 92201-97-3 93165-19-6 94114-03-1 95009-23-7 97926-43-7 98219-46-6 98219-47-7 101316-56-7 101316-66-9 101316-76-1 101795-01-1 102110-14-5 68476-50-6 68476-55-1 90989-39-2	287-502-5 287-500-4 292-636-2 292-694-9 295-281-1 295-551-9 295-323-9 309-868-8 298-725-2 292-625-2 309-867-2 292-626-8 266-013-0 309-971-8 292-609-5 283-483-2 266-016-7 292-624-7 266-021-4 292-622-6 269-929-9 295-548-2 293-766-2 273-077-3 295-543-5 295-541-4 293-767-8 295-292-1 295-295-8 295-329-1 310-170-0 310-171-6 266-012-5 302-688-0 302-689-6 302-690-1 302-692-2 302-693-8 292-635-7 232-349-1 232-443-2 232-453-7 265-041-0 265-042-6 265-046-8 265-192-2 270-077-5 271-025-4 271-727-0 272-186-3 272-931-2 309-945-6 265-066-7 265-067-2 265-068-8 265-073-5 265-086-6 265-095-5 270-088-5 270-349-3 271-267-0 295-315-5 295-430-0 295-436-3 295-440-5 295-446-8 309-871-4 265-055-7 265-056-2 270-686-6 272-185-8 295-311-3 295-431-6 295-441-0 295-794-0 309-974-4 309-987-5 265-065-1 265-070-9 270-660-4 270-687-1 270-794-3 270-993-5 271-008-1 271-058-4 272-895-8 273-271-8 285-509-8 295-279-0 297-401-8 297-458-9 297-465-7 297-466-2 265-075-6 265-085-0 267-563-4 267-565-5 270-344-6 270-658-3 271-631-9 271-632-4 271-634-5 273-266-0 295-447-3 265-150-3 265-151-9 265-178-6 270-092-7 270-093-2 270-094-8 270-988-8 285-511-9 285-512-4 295-432-1 295-433-7 295-438-4 295-443-1 295-529-9 296-942-7 297-852-0 297-853-6 265-047-3 265-048-9 265-071-4 265-079-8 265-089-2 265-115-2 265-122-0 265-123-6 265-170-2 265-187-5 265-199-0 268-618-5 270-725-7 270-735-1 270-736-7 270-738-8 270-741-4 270-771-8 270-791-7 270-795-9 270-991-4 271-138-9 271-262-3 271-263-9 271-264-4 271-266-5 271-635-0 271-726-5 272-206-0 272-896-3 272-932-8 285-510-3 289-220-8 292-698-0 295-298-4 295-302-4 295-331-2 295-434-2 295-442-6 295-444-7 295-445-2 296-028-8 296-903-4 302-639-3 305-750-5 308-261-5 308-713-1 308-714-7 309-862-5 309-870-9 309-879-8 309-976-5 310-012-0 270-690-8 270-695-5 292-695-4
1540	Xxxx, xxxx, dehet x xxxxx plyn x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx
		90640-85-0 92061-93-3 90640-84-9 61789-28-4 70321-79-8 122384-77-4 70321-80-1	292-606-9 295-506-3 292-605-3 263-047-8 274-565-9 310-189-4 274-566-4
1541	Xxxx, xxxx, dehet x xxxxx plyn x xxxxxx deriváty xxxxxxxxxx xx použití destilace x/xxxx xxxxxx xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxxxxx xxxx xxxxx obsahují ≥ 0,005 % hmotnostních xxxxx[x]xxxxxx
		85029-51-2 84650-04-4 84989-09-3 91995-49-2 121620-47-1 121620-48-2 90640-90-7 90641-04-6 101896-27-9 101794-91-6 91995-48-1 90641-05-7 84989-12-8 121620-46-0 90640-81-6 90640-82-7 92061-92-2 91995-15-2 91995-16-3 91995-17-4 101316-87-4 122384-78-5 84988-93-2 90640-88-3 65996-83-0 90640-89-4 90641-06-8 65996-85-2 101316-86-3 92062-22-1 96690-55-0 84989-04-8 84989-05-9 84989-06-0 84989-03-7 84989-07-1 68477-23-6 68555-24-8 91079-47-9 92062-26-5 94114-29-1 90641-00-2 68513-87-1 70321-67-4 92062-29-8 100801-63-6 100801-65-8 100801-66-9 73665-18-6 68815-21-4 65996-86-3 65996-84-1	285-076-5 283-484-8 284-898-1 295-310-8 310-166-9 310-167-4 292-612-1 292-627-3 309-985-4 309-972-3 295-309-2 292-628-9 284-901-6 310-165-3 292-603-2 292-604-8 295-505-8 295-275-9 295-276-4 295-278-5 309-889-2 310-191-5 284-881-9 292-610-0 266-017-2 292-611-6 292-629-4 266-019-3 309-888-7 295-536-7 306-251-5 284-892-9 284-893-4 284-895-5 284-891-3 284-896-0 270-713-1 271-418-0 293-435-2 295-540-9 302-662-9 292-623-1 271-020-7 274-560-1 295-544-0 309-745-9 309-748-5 309-749-0 277-567-8 272-361-4 266-020-9 266-018-8
1542	Xxxx, uhlí, dehet x xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxx-1,3-xxxxx
		68607-11-4 68783-06-2 68814-67-5 68814-90-4 68911-58-0 68911-59-1 68919-01-7 68919-02-8 68919-03-9 68919-04-0 68919-07-3 68919-08-4 68919-11-9 68919-12-0 68952-79-4 68952-80-7 68955-33-9 68989-88-8 92045-15-3 92045-16-4 92045-17-5 92045-18-6 92045-19-7 92045-20-0 68131-75-9 68307-98-2 68307-99-3 68308-00-9 68308-01-0 68308-10-1 68308-03-2 68308-04-3 68308-05-4 68308-06-5 68308-07-6 68308-09-8 68308-11-2 68308-12-3 68409-99-4 68475-57-0 68475-58-1 68475-59-2 68475-60-5 68476-26-6 68476-29-9 68476-40-4 68476-42-6 68476-49-3 68476-85-7 68476-86-8 68477-33-8 68477-35-0 68477-69-0 68477-70-3 68477-71-4 68477-72-5 68308-08-7	271-750-6 272-182-1 272-338-9 272-343-6 272-775-5 272-776-0 272-873-8 272-874-3 272-875-9 272-876-4 272-880-6 272-881-1 272-884-8 272-885-3 273-173-5 273-174-0 273-269-7 273-563-5 295-397-2 295-398-8 295-399-3 295-400-7 295-401-2 295-402-8 268-629-5 269-617-2 269-618-8 269-619-3 269-620-9 269-630-3 269-623-5 269-624-0 269-625-6 269-626-1 269-627-7 269-629-8 269-631-9 269-632-4 270-071-2 270-651-5 270-652-0 270-653-6 270-654-1 270-667-2 270-670-9 270-681-9 270-682-4 270-689-2 270-704-2 270-705-8 270-724-1 270-726-2 270-750-3 270-751-9 270-752-4 270-754-5 269-628-2
1543	Xxxx[2-xxxxx-1-(xxxxxxxxxxx)xxxxx]xxxxxx	13674-87-8	237-159-2
1544	Xxxxxx xxxxx	22398-80-7	244-959-5
1545	Xxxxxxxx-xxxxxx	25155-23-1	246-677-8
1546	Xxxxxxxxxxxxxxxxxxxx [1]	25637-99-4 [1]	247-148-4 [1]
1546	1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]	3194-55-6 [2]	221-695-9 [2]
1547	Xxxxxxxxxxxxxxx	109-99-9	203-726-8
1548	Xxxxxxxxx (xxxx avermektinu X1x a xxxxxxxxxxx X1x) (XXX) [1]	71751-41-2 [1]	615-339-5 [1]
1548	avermektin B1a [2]	65195-55-3 [2]	265-610-3 [2]
1549	4-Xxxx-xxxxxxxxxxxxx xxxxxxxx	98-73-7	202-696-3
1550	Xxxxxxxxxxxxxxxx zeleň; X,X,X′,X′-xxxxxxxxxxx-4,4′-xxxxxxxxxxxxxxxxxx	129-73-7	204-961-9
1551	Xxxxxxxxxxx (XXX); 2-(2-xxxxx)xxxxxxxxxxxx	3878-19-1	223-404-0
1552	Xxxxxxxxxxx (XXX); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx	67129-08-2	266-583-0
1553	Xx-xxxx-xxxxxxxxxxxx	110-05-4	203-733-6
1554	Xxxxxxxxxxxxxxxxxxxxx	993-16-8	213-608-8
1555	2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx	57583-34-3	260-828-5
1556	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	15571-58-1	239-622-4
1557	Xxxxxxxxxx (ISO); 2-[2-chlor-4-(methylsulfonyl)benzoyl]cyklohexan-1,3-dion	99105-77-8	619-394-6
1558	Bifenthrin (XXX); (2-methylbifenyl-3-yl)methyl-rel-(1R,3R)-3-[(1Z)-2-chlor-3,3,3-trifluorprop-1-en-1-yl]-2,2-dimethylcyklopropan-karboxylát	82657-04-3	617-373-6
1559	Dihexyl-ftalát	84-75-3	201-559-5
1560	Amonium-pentadekafluoroktanoát	3825-26-1	223-320-4
1561	Perfluoroktanová xxxxxxxx	335-67-1	206-397-9
1562	X-xxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxx-2-xx	2687-91-4	220-250-6
1563	Xxxxxxxxxxx (XXX); 6-xxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xx	189278-12-4	606-168-7
1564	Xxxxxxx xxxxx	1303-00-0	215-114-8
1565	Xxxxx-xxxxxx	108-05-4	203-545-4
1566	Xxxxxxxxx (ISO); 2-xxxxx-3-xxxxxx-6-xxxxxxxxxxx	74070-46-5	277-704-1
1567	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	57583-35-4	260-829-0
1568	Xxxxxxxxxxxxxxx-xxxxxxxxx	753-73-1	212-039-2
1569	4-Xxxxxxxxxxxxxxx	100-40-3	202-848-9
1570	Xxxxxxxxxxx (XXX); 2-(X-xxxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-xxxxxxxxxxxxxxx-2-xx-1-xx	87820-88-0	618-075-9
1571	Xxxxxxxxxx (XXX); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx	101205-02-1	405-230-9
1572	Xxxxxxxxx (ISO); 3-xxxxx-X-[3-xxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxx]-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xxxx	79622-59-6	616-712-5
1573	Xxxxxxxxxx (XXX); 1-[2-(2,4-xxxxxxxxxxxx)xxxxxx]-1X-1,2,4-xxxxxxx	66246-88-6	266-275-6
1574	Xxxxxxxxxx (ISO); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx	72490-01-8	276-696-7
1575	Xxxxxx	100-42-5	202-851-5
1576	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxx	97-99-4	202-625-6
1577	Xxxxxxxxxxx	50-00-0	200-001-8
1578	Xxxxxxxxxxxxxxx	30525-89-4	608-494-5
1579	Xxxxxxxxxx, xxxxxxxxxxxxxx	463-57-0	207-339-5
1580	Xxxxxxxxx (XXX); 1-xxxxx-3-[2-xxxx-2-(xxxxxxxxxxxx)xxxxxx]xxxxxxxx	57966-95-7	261-043-0
1581	Xxxxxxxxxxxxxxx, sloučeniny	—	—
1582	Tembotrion (XXX); 2-{2-chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyklohexan-1,3-dion	335104-84-2	608-879-8
1583	1,2-Benzendikarboxylová kyselina, xxxxxxxxxxxx, xxxxxxxxxx a xxxxxxxx	68515-50-4	271-093-5
1584	Xxxxxxxxxxxxx (XXX); (5s,8s)-3-(2,5-dimethylfenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dek-3-en-4-yl-ethylkarbonát	203313-25-1	606-523-6
1585	Dodemorf-acetát; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx	31717-87-0	250-778-2
1586	Xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-([4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxxxxxx	126535-15-7	603-146-9
1587	Xxxxxxxx (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx	35554-44-0	252-615-0
1588	Xxxxxxxx (XXX); 4-xxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx	1593-77-7	216-474-9
1589	Xxxxxxxx	288-32-4	206-019-2
1590	Xxxxxxx (XXX); 3-cyklohexyl-6,7-dihydro-1H-cyklopenta[d]pyrimidin-2,4(3H,5H)-dion	2164-08-1	218-499-0
1591	Metosulam (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx	139528-85-1	604-145-6
1592	2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-on	71868-10-5	400-600-6
1593	2,3-Epoxypropyl-methakrylát	106-91-2	203-441-9
1594	Spiroxamin (XXX) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx	118134-30-8	601-505-4
1595	Xxxxxxxx; xxxxxxxxxxx	420-04-2	206-992-3
1596	Xxxxxxxxxxxx (XXX); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx	94361-06-5	619-020-1
1597	Xxxxxxxx-xxxxxxxxx zeolit	130328-20-0	603-404-0
1598	Uhličitan xxxxxxxxx	513-78-0	208-168-9
1599	Xxxxxxxx xxxxxxxxx	21041-95-2	244-168-5
1600	Xxxxxxxx xxxxxxxxx	10325-94-7	233-710-6
1601	Xxxxxxxxxx-xxxxxxxx dibutyl[bis(dodekanoyloxy)]stannan	77-58-7	201-039-8
1602	Chlorofen; 2-xxxxxx-4-xxxxxxxxxx	120-32-1	204-385-8
1603	Xxxxxxxxxxxx	84-65-1	201-549-0
1604	Xxxxxxxxxxxxxxxxxxxxx kyselina [1]	335-76-2 [1]	206-400-3[1]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]	3108-42-7 [2]	221-470-5 [2] [3]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]	3830-45-3 [3]
1605	X,X′-xxxxxxxxxxxxxxxxxx; X,X′-xxxxxxxxxxxxxxxxxxx; [xxxxxxxxxxx xxxxxxxx x X,X′-xxxxxxxxxxxxxxxxxxxxx]; [XXX] xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx ohledu xx xxxxx xx xx xxxxx, xxx xx xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx	5625-90-1	227-062-3
1606	Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-hydroxypropylaminem (3:2); [formaldehyd xxxxxxxx x 3,3′-xxxxxxxxxxx [5–xxxxxxxxxxxxxxxxx]; [xxxxxxxxxxx xxxxxxxx x xxxxxxxxxxx]; [MBO], xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx uvolnitelného xxxxxxxxxxxx xxx xxxxxx xx xxxxx xx ve xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx	—	—
1607	Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-xxxxxxxxxxxxxxxxxxx (1:1); [xxxxxxxxxxx xxxxxxxx z α,α,α-trimethyl-1,3,5-triazin-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx teoretická xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx bez xxxxxx xx zdroj xx xx xxxxx, xxx xx uváděna xx xxx, ≥ 0,1 % hmotnostních	—	—
1608	Methylhydrazin	60-34-4	200-471-4
1609	Triadimenol (XXX); (1RS,2RS;1RS,2RS)-1-(4-chlorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol); α-xxxx-xxxxx-β-(4-xxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-1-xxxxxxx	55219-65-3	259-537-6
1610	Xxxxxxxxxxx (XXX); (Z)-3-(6-chlor-3-pyridylmethyl)-1-3-thiazolidin-2-ylidenkyanamid; {(2X)-3-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-1,3-xxxxxxxxxxx-2-xxxxxx}xxxxxxxx	111988-49-9	601-147-9
1611	Xxxxxxxxxx (XXX); (X)-1-(xxxxxxxxxxxxxx)xxxxxxxxxxxxxxx (2R)-1-(ethylamino)-1-oxopropan-2-yl-fenylkarbamát	16118-49-3	240-286-6“

položka 395 se xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx XXX

Xxxxx XX

„395

Xxxxxxxx-8-xx x xxxx xxxxxx

148-24-2

134-31-6

205-711-1

205-137-1“

2)&xxxx;&xxxx;&xxxx;

Xxxxxxx XXX se xxxx xxxxx:

x)	xxxxxxx 1x, 1x, 7, 13 x&xxxx;51 xx zrušují;

položka 12 xx nahrazuje xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Omezení

Znění xxxxxxxx xxxxxxx x xxxxxxxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx v xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx

Xxxxx XXX

Xxxxx XX

Xxxx xxxxxxx, části xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx k použití

Jiné

„12

Peroxid xxxxxx x ostatní xxxxxxxxxx nebo xxxxx, xxxxx xxxxxxx xxxxxx xxxxxxxx, xxxxxx látek xxxxxxxx xxxxxxx a xxxxxxx xxxxxxxxx, x xxxxxxxx xxxxxx xxxxx x xxxxxxx XX:

—	x. 1397, 1398, 1399

Xxxxxxxx xxxxxxxx

7722-84-1

231-765-0

x)	Xxxxxxxxx na xxxxx

x)	12 % X2X2 (40 xxxxxx), přítomného nebo xxxxxxxxxx

x) x) Xxxxxxxxxx xxxxxx rukavice.

a) x) x) x)

Xxxxxxxx xxxxxxx xxxxxx.

Xxxxxxxx xxxxx s xxxxx.

Xxx xxxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxx.

x)	Xxxxxxxxx xx xxxx

x)	4 % X2X2, přítomného xxxx xxxxxxxxxx

x)	Xxxxxxxxx xxx xxxxxxx xxxxx

x)	2 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx xxx xxxxx xxxxxxx, xxxxxx xxxxx xxxx, xxxxx xxxxx a xxxxxxxxx na xxxxxx xxxx xxxxxxxxxx xxxx

x)	≤ 0,1 % H2O2, xxxxxxxxxx xxxx uvolněného

e)	Přípravky xx xxxxxx xxxx xxxxxxxxxx xxxx

x)	&xx; 0,1 % ≤ 6 % X2X2, xxxxxxxxxx xxxx uvolněného

K xxxxxxx xxxxx zubním xxxxxxx. X každého xxxxx xxxxxxx xxxx xxx xxxxx použití provedeno xxxxxx xxxxxxx xx xxxxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 2005/36/XX&xxxx;(*1) nebo pod xxxx xxxxxx xxxxxxxx, xxxxx xx xxxxxxxx xxxxxxxxxx úroveň xxxxxxxxxxx.

Xxxx xxxxxx spotřebiteli x xxxxxxxxx xxxxx xxxxxxx.

Xxxxxxxxxx x xxxx xxxxxxxx 18 xxx.

Xxxxxxxxxxx X2X2 xxxxxxxxxx xxxx uvolněného xxxxxxx x procentech.

Nepoužívat x osob mladších 18 let.

K xxxxxxx xxxxx xxxxxx xxxxxxx. X xxxxxxx xxxxx xxxxxxx xxxx být xxxxx xxxxxxx xxxxxxxxx xxxxx xxxxxx lékařem xxxx xxx xxxx xxxxxx xxxxxxxx, xxxxx xx xxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx xxxxxxxxxxxx x xxxxxxxxx xxxxx xxxxxxx.

x)	Xxxxxxxxx xxxxxx xxx řasy

f)	2 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxx xxx xxxxxxxxxxxxx xxxxxxx.

Xx etiketě xx xxxxx:

„Xxx pro xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx styku s xxxxx.

Xxx zasažení xxx xxxxxxxx xxxxxxxxxxx xxxxx.

Xxxxxxxx xxxxxxx xxxxxx.“

xxxxxxxx xx xxxx položky, které xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx xxxxx				Xxxxxxx			Xxxxx xxxxxxxx použití a xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx xxxxx/ XXX	Xxxxx x xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx	Xxxxx XXX	Xxxxx XX	Xxxx xxxxxxx, části xxxx	Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx připraveném x xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„311	Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx oxid	Trimethylbenzoyl diphenylphosphine xxxxx	75980-60-8	278-355-8	Xxxxxxx xxxxxxx nehtů	5,0 %	Xxxxxxxxxxxxx xxxxxxx	Xxx xxx xxxxxxxxxxxxx použití. Zabraňte styku x xxxx. Xxxxx xxxxxxx xxxxx k xxxxxxx.
312	2-Xxxxxxxxxx	Xxxxxxxx	98-01-1	202-627-7		0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx X&xxxx;xx xxxx xxxxx:

x&xxxx;xxxxx se bod 2 xxxxxxxxx tímto:

„2.	Veškeré xxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxxxxxx x&xxxx;xxxx xxxxxxx, x&xxxx;xxxxx xx xxxxxxxx xxxxxxxxxxx, musí xxx xxxxxxxx xxxxxxxxxxx „xxxxxxxx xxxxxxxxxxx“, jestliže xxxxxxxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxxxx 0,05 %.“;

b)	položky 5, 31, 40 x&xxxx;41 xx zrušují;

položka 28 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx xxxxx				Xxxxxxxx			Xxxxx xxxxxxxx xxxxxxx a xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx název/INN	Název x xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx	Xxxxx CAS	Číslo XX	Xxxx výrobku, xxxxx xxxx	Xxxxxxxx koncentrace x xxxxxxxxx xxxxxxxxxxx x xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„28	Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx	Xxxxxxxxxxxxxxx biguanide	32289-58-0, 27083-27-8, 28757-47-3, 133029-32-0	608-723-9 608-042-7		0,1 %	Xxxxxxxxxx x aplikacích, xxx xxxxx xxxx k xxxxxxxx plic konečného xxxxxxxxx xxx vdechování.“

(*1) Směrnice Xxxxxxxxxx xxxxxxxxxx x Xxxx 2005/36/XX xx xxx 7. xxxx 2005 x xxxxxxxx xxxxxxxxx xxxxxxxxxxx (Úř. xxxx. X&xxxx;255, 30.9.2005, x.&xxxx;22).“

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.